The use of non-biomedical therapeutics and the management of cancer are high profile issues in health internationally. They both generate, in their own right, considerable debate amongst academics, practitioners and the wider public. Increasingly, as non-biomedical approaches have become more and more a feature of the range of therapeutic options available to cancer patients, the two have become inextricably linked. This book is concerned with that increasingly evident combination. Specifically, it is a socially located analysis of previously under-researched aspects of this coming together in both richer and poorer countries – namely, the UK, Australia and Pakistan
